Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-658-4 | CAS number: 2212-32-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
An acute oral toxicity study is available; waivers are provided for acute dermal toxicity and acute inhalation toxicity, based on the corrosivity of the substance.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- incomplete characterization of the test substance (no data on test substance purity available)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- Report title states test material is N, N, N Trimethylaminoethyl-Ethanolamin.
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
Further characterisation: KFM-Han. Wistar (outbred, SPF-Quality)
Source: Kleintierfarm Madoerin AG , CH 4414 Fuellinsdorf / Switzerland
Age at study initiation: 9 - 11 wks
Weight at study initiation: 201 - 227 g (males), 173 - 204 g (females)
Fasting period before study: 12 to 18 hours (access to water was not interrupted). Food was again presented approximately one hour after dosing.
Housing: Groups of five in Makrolon type-3 cages
Diet: Pelleted standard Kliba 343, Batch 47/86 rat maintenance diet ("Kliba", Klingentalmuehle AG, 4303 Kaiseraugst, Switzerland); available ad libitum
Water: Community tap water from Itingen; available ad libitum
Acclimation period: at least 7 day
Other: analysis of feed and water for contamination and nutrients indicated no variations that would affect the outcome of the study
ENVIRONMENTAL CONDITIONS
Temperature (°C): 22 ± 3 °C
Humidity (%): 40 - 70 %
Air changes (per hr): 10 - 15
Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- DOSAGE PREPARATION
The test article was placed into a glass beaker on a tared Mettler PK 4800 balance, and the vehicle (distilled water) was added. A weight by volume dilution was prepared using a homogenizer (Ultra-Turrax, Janke and Kunkel, Staufen, FRG). Homogeneity of the test article in the vehicle was maintained during treatment using a magnetic stirrer (Auer-Bittmann, 8953 Dietikon, Switzerland). The preparation was made immediately prior to dosing.
MAXIMUM DOSE VOLUME APPLIED: 20 mL/kg bw - Doses:
- 2,000, 3,200, 5,000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 15 days
Frequency of observations/mortality: Four times during test day 1, and daily during days 2-15
Frequency of weighing: Test days 1 (pre-administration), 8 and 15
Necropsy of survivors and animals that perished performed: yes - Statistics:
- The LOGIT-Model (COX, Analysis of Binary Data, London 1977) was applied to estimate the toxicity value. Additionally, the 90, 95 and 99% confidence intervals for the toxicity for each sex the slope of the dose response line were estimated.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 801 mg/kg bw
- Based on:
- test mat.
- Remarks:
- (in water)
- 95% CL:
- 2 235 - 3 346
- Remarks on result:
- other: Slope = 5.373
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3 081 mg/kg bw
- Based on:
- test mat.
- Remarks:
- (in water)
- 95% CL:
- 2 207 - 4 066
- Remarks on result:
- other: Slope = 5.242
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 570 mg/kg bw
- Based on:
- test mat.
- Remarks:
- (in water)
- 95% CL:
- 1 107 - 3 534
- Remarks on result:
- other: Slope = 3.913
- Mortality:
- Mortality: (out of 5 males and 5 females)
Number of dead males at doses 2,000, 3,200, 5,000 mg/kg bw: 0/3/5
Number of dead females at doses 2,000, 3,200, 5,000 mg/kg bw: 1/4/5 - Clinical signs:
- other: At 2,000 mg/kg bw: sedation, curved body position, ruffled fur At 3,200 mg/kg bw: sedation, ataxia, ventral body position (males), latero-abdominal position (females), curved body position, ruffled fur At 5,000 mg/kg bw: sedation, somnolence, ataxia, curv
- Gross pathology:
- Animals that died:
At 2,000 mg/kg bw: red discolouration of lungs, stomach/intestines was filled with test article
At 3,200 mg/kg bw: dark-red discolouration of the lungs, stomach/intestines were totally filled with test article and/or reddish fluid, dark reddish discolouration of the stomach and intestines, severe enlargement of the stomach
At 5,000 mg/kg bw: dark-red discolouration of the lungs (not collapsed), stomach/intestines were partly or totally filled with reddish fluid and test article, dark reddish discolouration of the stomach, enlargement of the stomach and intestines
Animals that were sacrificed:
No pathological changes seen at any dose level - Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The LD50 values were 3081 mg/kg bw (males), 2570 mg/kg bw (females) and 2801 mg/kg bw (combined males and females). The substance is not classified for acute toxicity accoridng to the CLP Regulation.
- Executive summary:
An acute oral toxicity was conducted in rats according to OECD 401 and EU methods B.1. N, N, N Trimethylaminoethyl-Ethanolamin was adminstered by oral gavage to 5 rats/sex/group at dose levels of 2000, 3200 and 5000 mg/kg bw. Mortality was observed at all doses; all animals dosed with 5000 mg/kg bw died, seven animals dosed with 3200 mg/kg bw died and one animal dosed with 2000 mg/kg bw died. Clinical signs included sedation, curved body position, ruffled fur, somnolence, ataxia and tremors. In those animals which died during the study, red discoloration of the lungs, stomach and intestines filled with test article and/or red fluid, red discolouration of the stomach and intestines and enlargemet of the stomach and intestines were observed. No pathological changes were noted in animals surviving to the scheduled termination. The LD50 values were 3081 mg/kg bw (males), 2570 mg/kg bw (females) and 2801 mg/kg bw (combined males and females). In accordance with CLP, classification for acute oral toxicity is not required.
Reference
Mortality (out of 5/sex/dose)
|
|
|
|
|
|
|
|
Dose (mg/kg bw) |
Gender |
2 h |
3 h |
5 h |
7 h |
24 h |
Total after 15 days |
2,000 |
male |
0 |
0 |
0 |
0 |
0 |
0 |
female |
0 |
0 |
0 |
0 |
1 |
1 |
|
3,200 |
male |
0 |
1 |
0 |
0 |
2 |
3 |
female |
0 |
0 |
1 |
2 |
1 |
4 |
|
5,000 |
male |
0 |
0 |
1 |
2 |
2 |
5 |
female |
0 |
1 |
3 |
0 |
1 |
5 |
Mean weight (g)
Dose (mg/kg bw) |
Gender |
Day 1 |
Day 8 |
Day 15 |
2000 |
male |
214 ± 8.1 |
248 ± 11 |
279 ± 14 |
female |
193 ± 5.4 |
204 |
222 |
|
3200 |
male |
205 ± 7.7 |
229 |
265 |
female |
180 ± 3.7 |
201 |
228 |
|
5000 |
male |
213 ± 6.9 |
All dead |
- |
female |
185 ± 13 |
All dead |
- |
Clinical signs
Dose (mg/kg bw) |
2000 |
3200 |
5000 |
|||
|
male |
female |
male |
female |
male |
female |
Sedation |
≤ 24 hours |
≤ 24 hours |
≤ 6 days |
≤ 6 days |
2 – 5 h |
2 – 5 h |
Curved body position |
≤ 24 hours |
≤ 24 hours |
≤ 5 days |
≤ 5 days |
2 – 5 h |
2 – 5 h |
Ruffled fur |
≤ 48 hours |
≤ 48 hours |
≤ 6 days |
≤ 6 days |
2 – 5 h |
2 – 5 h |
Ataxia |
- |
- |
≤ 5 days |
≤ 5 days |
2 – 5 h |
2 – 5 h |
Central body position |
- |
- |
2 h |
- |
- |
- |
Latero-abd-pos |
- |
- |
- |
2 – 5 h |
- |
- |
Tremor |
- |
- |
- |
- |
2 – 5 h |
2 – 5 h |
Somnolence |
- |
- |
- |
- |
2 – 5 h |
2 – 5 h |
h: hour
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 570 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
An acute oral toxicity was conducted in rats according to OECD 401 and EU methods B.1. N, N, N Trimethylaminoethyl-Ethanolamin was adminstered by oral gavage to 5 rats/sex/group at dose levels of 2000, 3200 and 5000 mg/kg bw. Mortality was observed at all doses; all animals dosed with 5000 mg/kg bw died, seven animals dosed with 3200 mg/kg bw died and one animal dosed with 2000 mg/kg bw died. Clinical signs included sedation, curved body position, ruffled fur, somnolence, ataxia and tremors. In those animals which died during the study, red discoloration of the lungs, stomach and intestines filled with test article and/or red fluid, red discolouration of the stomach and intestines and enlargemet of the stomach and intestines were observed. No pathological changes were noted in animals surviving to the scheduled termination. The LD50 values were 3081 mg/kg bw (males), 2570 mg/kg bw (females) and 2801 mg/kg bw (combined males and females). In accordance with CLP, classification for acute oral toxicity is not required.
Waivers are provided for acute dermal toxicity and acute inhalation toxicity, based on the corrosivity of the substance.
Justification for classification or non-classification
No classification for acute oral toxicity is required, based on the available study. LD50 values are reported to be >2000 mg/kg bw; therefore classification under CLP is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
